COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study-Reference-Cited by-同舟云学术

COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study

Published:2022-04 Issue:4 Volume:7 Page:342-352
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Alexander James L,Kennedy Nicholas A,Ibraheim Hajir,Anandabaskaran Sulak,Saifuddin Aamir,Castro Seoane Rocio,Liu Zhigang,Nice Rachel,Bewshea Claire,D'Mello Andrea,Constable Laura,Jones Gareth R,Balarajah Sharmili,Fiorentino Francesca,Sebastian Shaji,Irving Peter M,Hicks Lucy C,Williams Horace R T,Kent Alexandra J,Linger Rachel,Parkes Miles,Kok Klaartje,Patel Kamal V,Teare Julian P,Altmann Daniel M,Boyton Rosemary J,Goodhand James R,Hart Ailsa L,Lees Charlie W,Ahmad Tariq,Powell Nick,Chukwurah Ijeoma,Haq Sulaimaan,Shah Parita,Wilken-Smith Stephanie,Ramanathan Anitha,Patel Mikin,Romanczuk Lidia,King Rebecca,Domingo Jason,Shamtally Djamila,Mendoza Vivien,Sanchez Joanne,Stark Hannah,Knight Bridget,Bee Louise,Estember Charmaine,Barnes Anna,Watkins Darcy,Stone Sam,Kirkwood John,Parkinson Marian,Gardner-Thorpe Helen,Covil Kate,Derikx Lauranne,Gros Alcalde Beatriz,Lee Irish,Cipriano Bessie,Ruocco Giuseppe,Baden Manisha,Cooke Graham,Pollock Katrina

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference29 articles.

1. Effectiveness of the Pfizer-BioNTech and Oxford-AstraZeneca vaccines on covid-19 related symptoms, hospital admissions, and mortality in older adults in England: test negative case-control study;Lopez Bernal;BMJ,2021

2. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies;Ng;Lancet,2017

3. Antibody response to hepatitis B virus vaccine is impaired in patients with inflammatory bowel disease on infliximab therapy;Pratt;Inflamm Bowel Dis,2018

4. Effects of immunosuppression on immune response to pneumococcal vaccine in inflammatory bowel disease: a prospective study;Fiorino;Inflamm Bowel Dis,2012

5. Immunosuppression impairs response to pneumococcal polysaccharide vaccination in patients with inflammatory bowel disease;Melmed;Am J Gastroenterol,2010

Cited by 117 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell responses to repeated SARS-CoV-2 vaccination and breakthrough infections in patients on TNF inhibitor treatment: a prospective cohort study;eBioMedicine;2024-10

2. Impacto de la mesalazina en la respuesta a la vacunación contra la COVID-19 en pacientes con enfermedad inflamatoria intestinal. Resultados de un estudio prospectivo multicéntrico de GETECCU (VACOVEII);Gastroenterología y Hepatología;2024-08

3. Impact of mesalazine on the response to COVID-19 vaccination in patients with inflammatory bowel disease: Results of a prospective multicentre study of GETECCU (VACOVEII study);Gastroenterología y Hepatología (English Edition);2024-08

4. Live-attenuated vaccination in patients with inflammatory bowel disease while continuing or after elective switch to vedolizumab;Intestinal Research;2024-07-31

5. Duration of Postvaccination Neutralizing Antibodies to SARS‐CoV‐2 and Medication Effects: Results from the Safety and Immunogenicity of COVID‐19 Vaccination in Systemic Immune‐Mediated Inflammatory Diseases Cohort Study;ACR Open Rheumatology;2024-07